LAMISIL 250
Generic Name: terbinafine
Pill imprint LAMISIL 250 has been identified as Lamisil 250 mg.
Lamisil is used in the treatment of tinea corporis; onychomycosis, toenail; cutaneous candidiasis; tinea pedis; tinea capitis (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy.
Lamisil 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Lamisil Images
- Generic Name:
- terbinafine
- Imprint:
-
LAMISIL
250 - Strength:
- 250 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0179
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0513 | PDRX Pharmaceuticals Inc (repackager) |
| 54868-4008 | Physicians Total Care Inc (repackager) |
| 49999-0466 | Lake Erie Medical and Surgical Supply (repackager) |
| 23490-6961 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Lamisil resources
- Lamisil
- Lamisil (Wolters Kluwer)
- Lamisil Oral Granules (Wolters Kluwer)
- Lamisil (Cerner Multum)
- Lamisil (Micromedex) - Includes Dosage Information
- Lamisil (AHFS DI)
- Lamisil (FDA)
- Lamisil Oral Granules (FDA)
Search Again
